VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ESH CML 2022 | The impact of ACA in CML & the importance of monitoring these patients

Susanne Saussele, MD, University of Heidelberg, Mannheim, Germany, highlights the importance of monitoring in patients with chronic myeloid leukemia (CML) with additional chromosomal abnormalities (ACA). This interview took place at the 24th Annual John Goldman Conference on Chronic Myeloid Leukemia (ESH CML) held in Mandelieu-La Napoule, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

BMS, Incyte, Novartis, Honoraria: BMS, Incyte, Novartis, Pfizer, Roche

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter